BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1412460)

  • 21. Renal excretion of proteins and enzymes in workers exposed to cadmium.
    Bernard A; Buchet JP; Roels H; Masson P; Lauwerys R
    Eur J Clin Invest; 1979 Feb; 9(1):11-22. PubMed ID: 110596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of 6-keto-PGF1 alpha, 2,3-dinor-6-keto-PGF1 alpha, thromboxane B2, 2,3-dinor-thromboxane B2, PGE2, PGD2 and PGF2 alpha in human urine by gas chromatography-negative ion chemical ionization mass spectrometry.
    Weber C; Höller M; Beetens J; De Clerck F; Tegtmeier F
    J Chromatogr; 1991 Jan; 562(1-2):599-611. PubMed ID: 2026723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal synthesis and urinary excretion of eicosanoids during pregnancy in rats.
    Conrad KP; Dunn MJ
    Am J Physiol; 1987 Dec; 253(6 Pt 2):F1197-205. PubMed ID: 3480695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disturbance of sialic acid metabolism by chronic cadmium exposure and its relation to proteinuria.
    Cardenas A; Bernard AM; Lauwerys RR
    Toxicol Appl Pharmacol; 1991 May; 108(3):547-58. PubMed ID: 2020976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity.
    Roels HA; Hoet P; Lison D
    Ren Fail; 1999; 21(3-4):251-62. PubMed ID: 10416202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of urinary protein 1 and transferrin as early markers of cadmium nephrotoxicity.
    Bernard AM; Roels H; Cardenas A; Lauwerys R
    Br J Ind Med; 1990 Aug; 47(8):559-65. PubMed ID: 2203466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PGE2, PGF2 alpha, 6-keto-PGF1 alpha, and TxB2 synthesis along the rabbit nephron.
    Farman N; Pradelles P; Bonvalet JP
    Am J Physiol; 1987 Jan; 252(1 Pt 2):F53-9. PubMed ID: 3101513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-level cadmium exposure and effects on kidney function.
    Wallin M; Sallsten G; Lundh T; Barregard L
    Occup Environ Med; 2014 Dec; 71(12):848-54. PubMed ID: 25286916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of protein intake and unilateral nephrectomy on renal function and eicosanoid excretion in rats.
    De Keijzer MH; Provoost AP
    Miner Electrolyte Metab; 1992; 18(2-5):113-6. PubMed ID: 1465043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary calcium as a biomarker of renal dysfunction in a general population exposed to cadmium.
    Wu X; Jin T; Wang Z; Ye T; Kong Q; Nordberg G
    J Occup Environ Med; 2001 Oct; 43(10):898-904. PubMed ID: 11665459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of glomerular polyanion correlated with albuminuria in experimental cadmium nephropathy.
    Bernard A; Lauwerys R; Ouled Amor A
    Arch Toxicol; 1992; 66(4):272-8. PubMed ID: 1514926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal eicosanoids and renal hemodynamics in early borderline hypertension.
    Lebel M; Grose JH
    Clin Invest Med; 1991 Dec; 14(6):525-34. PubMed ID: 1794206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bladder contributes to eicosanoids excreted in urine.
    Reyes AA; Klahr S
    Am J Physiol; 1990 Nov; 259(5 Pt 2):F859-61. PubMed ID: 2240235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of starvation on the urinary contents of primary thromboxane and prostacyclin metabolites and a possible selenium-dependent role of prostacyclin in the renal handling of ketone bodies.
    Olsson U
    Prostaglandins Leukot Essent Fatty Acids; 1993 May; 48(5):385-90. PubMed ID: 8321875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of renal hemodynamics by renal eicosanoids during vasopressor infusions in man.
    Lebel M; Grose JH; Falardeau P
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jan; 35(1):41-9. PubMed ID: 2928372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the filtration reserve capacity of the kidney in workers exposed to cadmium.
    Roels HA; Lauwerys RR; Bernard AM; Buchet JP; Vos A; Oversteyns M
    Br J Ind Med; 1991 Jun; 48(6):365-74. PubMed ID: 2064974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro renal eicosanoid production during pregnancy in rabbits.
    Brown GP; Venuto RC
    Am J Physiol; 1988 Jun; 254(6 Pt 1):E687-93. PubMed ID: 3287949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prostaglandin E2, F2 alpha,6-keto-prostaglandin F1 alpha and thromboxane B2 in the placenta of normotensive women and women with pregnancy induced hypertension].
    Gao J
    Zhonghua Fu Chan Ke Za Zhi; 1989 Nov; 24(6):331-3, 380. PubMed ID: 2632162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of eicosanoids on renal function of DOCA-salt hypertensive rats.
    Roman RJ; Kaldunski ML; Mattson DL; Mistry M; Nasjletti A
    Hypertension; 1988 Sep; 12(3):287-94. PubMed ID: 3169943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.